Novel biomolecules in targeted cancer therapy: a new approach towards precision medicine-Reference-Cited by-同舟云学术

Novel biomolecules in targeted cancer therapy: a new approach towards precision medicine

Published:2023-10-07 Issue:11 Volume:40 Page:
ISSN:1559-131X
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Kannampuzha Sandra,Murali Reshma,Gopalakrishnan Abilash Valsala^ORCID,Mukherjee Anirban Goutam,Wanjari Uddesh Ramesh,Namachivayam Arunraj,George Alex,Dey Abhijit,Vellingiri Balachandar

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12032-023-02168-6.pdf

Reference172 articles.

1. Dragojevic S, Ryu JS, Raucher D. Polymer-based prodrugs: improving tumor targeting and the solubility of small molecule drugs in cancer therapy. Molecules. 2015;20(12):21750–69.

2. Silverman GJ. Anti-CD20 therapy and autoimmune disease: therapeutic opportunities and evolving insights. Front Biosci. 2007;12:2194–206.

3. Browning JL. B cells move to centre stage: novel opportunities for autoimmune disease treatment. Nat Rev Drug Discov. 2006;5(7):564–76.

4. Feugier P, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol. 2005;23(18):4117–26.

5. Gerber DE. Targeted therapies: a new generation of cancer treatments. Am Fam Physician. 2008;77(3):311–9.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unleashing the Potential of Camptothecin: Exploring Innovative Strategies for Structural Modification and Therapeutic Advancements;Journal of Medicinal Chemistry;2024-02-29

2. miRNA-Based Technologies in Cancer Therapy;Journal of Personalized Medicine;2023-11-09